Status: current, Defined. Date: 31-Aug 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2027621000168115 | empagliflozin + linagliptin (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2027631000168117 | empagliflozin + linagliptin | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| empagliflozin + linagliptin | Is a | empagliflozin | true | Inferred relationship | Some | ||
| empagliflozin + linagliptin | Is a | linagliptin | true | Inferred relationship | Some | ||
| empagliflozin + linagliptin | has intended active ingredient | empagliflozin | true | Inferred relationship | Some | 2 | |
| empagliflozin + linagliptin | has intended active ingredient | linagliptin | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| empagliflozin 10 mg + linagliptin 5 mg tablet | Is a | True | empagliflozin + linagliptin | Inferred relationship | Some | |
| empagliflozin 25 mg + linagliptin 5 mg tablet | Is a | True | empagliflozin + linagliptin | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR